Endocrinology Practice Questions

Q: What is a stimulus for insulin secretion?

Growth hormone. ### Explanation **1. Why Growth Hormone (GH) is the Correct Answer:** Growth hormone is a potent **diabetogenic hormone**. It stimulates insulin secretion through two primary mechanisms: * **Direct Action:** GH directly stimulates the pancreatic beta cells to secrete insulin. * **Indirect Action (Insulin Resistance):** GH decreases glucose uptake in peripheral tissues (muscle and fat) and increases hepatic gluconeogenesis. This leads to an increase in blood glucose levels (post-receptor insulin resistance), which subsequently acts as a potent feedback stimulus for further insulin release. **2. Analysis of Incorrect Options:** * **A. Somatostatin:** This is a universal inhibitory hormone. In the pancreas, delta cells secrete somatostatin, which acts via paracrine signaling to **inhibit** the secretion of both insulin and glucagon. * **C. Diuretics:** Specifically, Thiazide diuretics are known to **inhibit** insulin secretion (often leading to hyperglycemia) by opening ATP-sensitive potassium channels or causing hypokalemia, which hyperpolarizes the beta-cell membrane. * **D. α-agonist:** Adrenergic control of insulin is dual-natured. However, **α2-adrenergic stimulation** is the dominant effect of catecholamines on the pancreas, resulting in the **inhibition** of insulin secretion. (Conversely, β2-agonists stimulate insulin release). **3. High-Yield Clinical Pearls for NEET-PG:** * **Most Potent Stimulus:** The most potent physiological stimulus for insulin secretion is **Glucose**. * **Incretin Effect:** Oral glucose causes a greater insulin response than intravenous glucose due to GIP and GLP-1 (Incretins). * **Amino Acids:** Arginine and Lysine are strong stimulators of insulin. * **Autonomic Control:** Parasympathetic (Vagal) stimulation **increases** insulin, while Sympathetic (α-effect) **decreases** it. * **Hormonal Stimuli:** Glucagon, Cortisol, and GH all increase insulin secretion (diabetogenic hormones).

Q: Low levels of dopamine produced by the hypothalamus is a pathologic condition associated with which of the blood hormone levels?

High prolactin (PRL). **Explanation:** The correct answer is **A. High prolactin (PRL)**. **1. Why it is correct:** In the hypothalamus-pituitary axis, dopamine acts as the primary **Prolactin-Inhibiting Hormone (PIH)**. Unlike most other anterior pituitary hormones which require a "releasing hormone" to be secreted, prolactin is under **tonic (constant) inhibition** by dopamine. Dopamine is secreted by the tuberoinfundibular neurons of the hypothalamus into the hypophyseal portal system, where it binds to D2 receptors on lactotrophs. Therefore, any pathological condition that lowers hypothalamic dopamine levels or obstructs its flow to the pituitary (e.g., pituitary stalk compression) results in "disinhibition," leading to **hyperprolactinemia**. **2. Why other options are incorrect:** * **B. High TSH:** TSH is primarily regulated by Thyrotropin-Releasing Hormone (TRH). While dopamine has a minor inhibitory effect on TSH, low dopamine is not the primary driver of pathological TSH elevation. * **C. High cortisol:** Cortisol is regulated by ACTH from the pituitary and CRH from the hypothalamus. Dopamine does not play a significant role in this axis. * **D. Low growth hormone (GH):** Dopamine actually stimulates GH secretion in healthy individuals. Therefore, low dopamine would more likely lead to decreased GH, but this is not the classic clinical association compared to the profound effect on prolactin. **Clinical Pearls for NEET-PG:** * **Stalk Effect:** Any lesion compressing the pituitary stalk (e.g., Craniopharyngioma) prevents dopamine from reaching the pituitary, causing elevated prolactin. * **Drug-Induced Hyperprolactinemia:** Antipsychotics (D2 antagonists) are a common cause of high prolactin, leading to galactorrhea and amenorrhea. * **TRH Connection:** In primary hypothyroidism, high TRH levels can also stimulate lactotrophs, causing hyperprolactinemia.

Q: c-AMP acts as a second messenger for all of the following hormones, EXCEPT:

GH. **Explanation:** The mechanism of hormone action is determined by the chemical nature of the hormone and its specific receptor. Hormones that utilize **c-AMP (Cyclic Adenosine Monophosphate)** as a second messenger typically bind to G-protein coupled receptors (GPCRs) that activate Adenylate Cyclase. **1. Why GH is the correct answer:** **Growth Hormone (GH)**, along with Prolactin and Insulin, does not use the c-AMP pathway. Instead, GH binds to a single-transmembrane receptor that activates the **JAK-STAT pathway** (Janus Kinase-Signal Transducer and Activator of Transcription). This involves tyrosine kinase activity rather than the activation of G-proteins and secondary messengers like c-AMP. **2. Why the other options are incorrect:** * **TSH (Thyroid Stimulating Hormone):** Acts via the Gs-protein coupled receptor to increase c-AMP, which stimulates thyroid hormone synthesis and release. * **LH (Luteinizing Hormone):** Like FSH and hCG, LH utilizes the c-AMP pathway to stimulate steroidogenesis in the gonads (Leydig cells in males and Theca cells in females). * **Glucagon:** Binds to GPCRs in the liver to increase c-AMP levels, which subsequently activates Protein Kinase A (PKA) to promote glycogenolysis and gluconeogenesis. **High-Yield Clinical Pearls for NEET-PG:** * **JAK-STAT Pathway Mnemonic:** Remember **"PIG"** – **P**rolactin, **I**mmunomodulators (Cytokines/Interleukins), and **G**rowth Hormone. * **c-AMP Pathway:** Used by **FLAT ChAMP** (FSH, LH, ACTH, TSH, CRH, hCG, ADH (V2 receptor), MSH, PTH) and Glucagon. * **IP3/DAG Pathway:** Used by **GOAT** (GnRH, Oxytocin, ADH (V1 receptor), TRH). * **cGMP Pathway:** Used by ANP, BNP, and Nitric Oxide (NO).

Q: Which of the following is NOT a stimulus for insulin secretion?

Hypokalemia. **Explanation:** Insulin secretion from the pancreatic beta cells is a highly regulated process. The correct answer is **Hypokalemia** because low serum potassium levels actually **inhibit** insulin release. **1. Why Hypokalemia is the correct answer:** The mechanism of insulin secretion depends on the closure of ATP-sensitive $K^+$ channels, leading to cell depolarization and calcium influx. In **hypokalemia**, the cell membrane becomes hyperpolarized (more negative), making it harder for the cell to depolarize. This inhibits the release of insulin, which can clinically manifest as glucose intolerance in patients with low potassium levels. **2. Why the other options are stimuli for insulin:** * **Glucagon (A):** Glucagon acts via a paracrine mechanism to directly stimulate beta cells to secrete insulin. This ensures that as glucagon raises blood glucose, insulin is available to facilitate glucose uptake. * **Ketone bodies (C):** Elevated levels of ketones (like acetoacetate) act as a feedback signal to stimulate insulin, which in turn inhibits further lipolysis and ketogenesis, preventing ketoacidosis in healthy individuals. * **Amino acids (D):** Arginine and Lysine are potent stimulators of insulin secretion. They depolarize the beta cell membrane directly or via co-transport with sodium. **Clinical Pearls for NEET-PG:** * **The "Incretin Effect":** Oral glucose causes a much greater insulin response than IV glucose due to the release of GIP and GLP-1 from the gut. * **Potassium Connection:** Insulin therapy causes an intracellular shift of potassium. Therefore, always monitor for hypokalemia when treating Diabetic Ketoacidosis (DKA) with insulin. * **Drug Correlation:** Sulfonylureas stimulate insulin by blocking the same ATP-sensitive $K^+$ channels mentioned above.

Q: What is the effect of cortisol?

Decreased bone matrix. **Explanation:** Cortisol (the primary glucocorticoid) has profound effects on bone metabolism and hematology. **Why Option A is Correct:** Cortisol causes a **decrease in bone matrix** through several mechanisms. It inhibits **osteoblast** (bone-forming cell) activity and protein synthesis (collagen type I), while simultaneously stimulating **osteoclast** (bone-resorbing cell) activity. Furthermore, cortisol decreases intestinal calcium absorption and increases renal calcium excretion, leading to secondary hyperparathyroidism, which further accelerates bone loss. This is why chronic steroid use is a major risk factor for osteoporosis. **Analysis of Incorrect Options:** * **Option B:** Incorrect, as cortisol is catabolic to bone and connective tissue. * **Option C:** Incorrect. Cortisol causes **lymphocytopenia**, eosinopenia, and monocytopenia by sequestering these cells into the spleen and bone marrow and inducing apoptosis in T-cells. * **Option D:** While cortisol does stimulate erythropoiesis (increasing RBC count), it is not the classic "textbook" primary effect often tested in the context of bone matrix pathology. However, in many competitive exams, if "Decreased bone matrix" is an option, it is prioritized due to its significant clinical implication in Cushing’s syndrome. **NEET-PG High-Yield Pearls:** * **Hematological "Rule of Thumb":** Cortisol **increases** "B-N-P" (Blood pressure, Neutrophils, Platelets/RBCs) and **decreases** "L-E-M" (Lymphocytes, Eosinophils, Monocytes). * **Neutrophilia:** Cortisol causes neutrophilia by decreasing the "marginal pool" (preventing neutrophils from sticking to vessel walls). * **Cushing’s Syndrome:** Characterized by osteoporosis, pathological fractures, and "buffalo hump" due to fat redistribution despite muscle wasting (proteolysis).

Q: Which of the following is NOT an effect of the T3 hormone?

It decreases pulse pressure. **Explanation:** The thyroid hormone (T3) has profound effects on the cardiovascular system, primarily acting to increase cardiac output and meet the body's metabolic demands. **Why Option D is the Correct Answer:** T3 **increases pulse pressure**, it does not decrease it. Pulse pressure is the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP). T3 increases SBP (due to increased stroke volume and contractility) and decreases DBP (due to vasodilation). This widening of the gap results in a **wide pulse pressure**, a classic clinical sign of hyperthyroidism. **Analysis of Incorrect Options:** * **A. Increases Heart Rate:** T3 has a direct chronotropic effect by upregulating $\beta_1$-adrenergic receptors in the heart and increasing the rate of depolarization in the SA node. * **B. Increases Stroke Volume:** T3 exerts a positive inotropic effect by increasing the expression of $\alpha$-myosin heavy chains and SERCA (sarcoplasmic reticulum calcium ATPase), enhancing myocardial contractility and stroke volume. * **C. Decreases Peripheral Resistance:** T3 causes direct vasodilation of peripheral arterioles by increasing local metabolic end-products and decreasing systemic vascular resistance (SVR). **NEET-PG High-Yield Pearls:** * **Hyperthyroidism:** Characterized by tachycardia, palpitations, and a "bounding pulse" (due to wide pulse pressure). * **Hypothyroidism:** Characterized by bradycardia and a "narrow pulse pressure." * **Molecular Mechanism:** T3 increases the transcription of the **SERCA2 pump**, which improves calcium sequestration during diastole, leading to faster relaxation (lusitropic effect) and stronger subsequent contraction.

Q: A middle-aged man notices that he can no longer fit in his shoes and observes enlargement of his jaw and phalanges. Which hormone mediates these effects?

Somatomedin. ### Explanation The clinical presentation of increasing shoe size, jaw enlargement (prognathism), and phalangeal thickening in an adult is classic for **Acromegaly**, which results from the hypersecretion of Growth Hormone (GH) after epiphyseal closure [2]. **Why Somatomedin is Correct:** While GH is the primary hormone secreted by the pituitary adenoma, its peripheral effects—especially linear and bony growth—are mediated by **Somatomedin C**, also known as **Insulin-like Growth Factor 1 (IGF-1)** [1]. GH stimulates the liver to produce IGF-1, which then acts on tissues to promote protein synthesis and skeletal growth [1]. In clinical practice, measuring serum IGF-1 is the most reliable screening test for Acromegaly because it has a longer half-life and lacks the pulsatile secretion pattern of GH [3]. **Why the Other Options are Incorrect:** * **ACTH (A):** Stimulates the adrenal cortex to produce cortisol. Excess leads to Cushing’s syndrome (moon face, buffalo hump), not bony enlargement. * **TRH (B):** A hypothalamic hormone that stimulates the release of TSH and Prolactin. It does not mediate bone or soft tissue growth. * **TGF-beta (D):** A cytokine involved in cell growth, differentiation, and development, but it is not the mediator of GH-induced systemic growth in Acromegaly. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Test:** Serum IGF-1 levels (Somatomedin C). * **Confirmatory Test:** Oral Glucose Tolerance Test (OGTT) with GH measurement [3]. Failure to suppress GH <1 ng/mL after 75g glucose is diagnostic. * **Most Common Cause:** Somatotroph adenoma of the anterior pituitary. * **Radiology:** Look for "spade-like" phalanges on X-ray and enlargement of the sella turcica on MRI. * **Treatment of Choice:** Transsphenoidal surgery [3]. Medical management includes Somatostatin analogues (Octreotide).

Q: Which of the following glucose transporters is insulin-dependent for its action?

GLUT 4. **Explanation:** The correct answer is **GLUT 4**. Glucose transporters (GLUTs) are membrane proteins that facilitate the transport of glucose across cell membranes via facilitated diffusion. **GLUT 4** is the only major glucose transporter that is **insulin-dependent**. In the resting state, GLUT 4 is sequestered in intracellular vesicles. When insulin binds to its receptor, it triggers a signaling cascade that causes these vesicles to translocation and fuse with the plasma membrane, allowing glucose entry into the cell. **Analysis of Options:** * **GLUT 1:** Found in RBCs, the blood-brain barrier, and the heart. It provides basal glucose uptake and is insulin-independent. * **GLUT 2:** A high-capacity, low-affinity transporter found in the Liver, Pancreatic beta cells, and the Basolateral membrane of the kidney/intestine. It acts as a "glucose sensor" and is insulin-independent. * **GLUT 3:** Found primarily in Neurons and the placenta. It has a high affinity for glucose, ensuring brain uptake even during hypoglycemia; it is insulin-independent. **High-Yield Clinical Pearls for NEET-PG:** * **Location of GLUT 4:** Primarily found in **Skeletal muscle** and **Adipose tissue**. * **Exercise:** Muscle contraction can also trigger GLUT 4 translocation to the membrane independent of insulin, which is why exercise helps manage blood sugar in Type 2 Diabetes. * **SGLT vs. GLUT:** Remember that SGLT (Sodium-Glucose Linked Transporters) use **secondary active transport** (found in the kidney and gut), whereas GLUTs use **facilitated diffusion**. * **GLUT 5:** Specifically transports **Fructose** (found in the small intestine and spermatozoa).

Question 1

What is a stimulus for insulin secretion?

Accepted Answer

Growth hormone

Answer

Somatostatin

Answer

Diuretics

Answer

a-agonist

Question 2

A 48-year-old male patient, known diabetic on insulin with truncal obesity, presents for a routine checkup. The agent used in the treatment of this patient has all the following actions except?

Accepted Answer

Adipose tissue is less sensitive to it than many other tissues.

Answer

It inhibits the release of free fatty acids (FFA) from adipose tissue.

Answer

It enhances the uptake of glucose into adipose cells via the GLUT4 transporter.

Answer

In adipose tissue, it inhibits the activity of hormone-sensitive lipase.

Question 3

Low levels of dopamine produced by the hypothalamus is a pathologic condition associated with which of the blood hormone levels?

Accepted Answer

High prolactin (PRL)

Answer

High TSH

Answer

High cortisol

Answer

Low growth hormone (GH)

Question 4

c-AMP acts as a second messenger for all of the following hormones, EXCEPT:

Accepted Answer

GH

Answer

TSH

Answer

LH

Answer

Glucagon

Question 5

The metabolic functions of insulin include all of the following except?

Accepted Answer

Increased lipoprotein lipase activity

Answer

Increased glycogen synthesis in the liver

Answer

Decreased hepatic gluconeogenesis

Answer

Increased transport of glucose into deep tissues

Question 6

Which of the following is NOT a stimulus for insulin secretion?

Accepted Answer

Hypokalemia

Answer

Glucagon

Answer

Ketone bodies

Answer

Amino acids

Question 7

What is the effect of cortisol?

Accepted Answer

Decreased bone matrix

Answer

Increased bone matrix

Answer

Increases lymphocytes

Answer

Increases RBCs

Question 8

Which of the following is NOT an effect of the T3 hormone?

Accepted Answer

It decreases pulse pressure

Answer

It increases the heart rate

Answer

It increases the stroke volume

Answer

It decreases the peripheral resistance

Question 9

A middle-aged man notices that he can no longer fit in his shoes and observes enlargement of his jaw and phalanges. Which hormone mediates these effects?

Accepted Answer

Somatomedin

Answer

Adrenocorticotropic hormone (ACTH)

Answer

Thyrotropin-releasing hormone (TRH)

Answer

Transforming growth factor beta (TGF-beta)

Question 10

Which of the following glucose transporters is insulin-dependent for its action?

Accepted Answer

GLUT 4

Answer

GLUT 1

Answer

GLUT 2

Answer

GLUT 3

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?